Redcare Pharmacy NV (ETR:RDC)
Germany · Delayed Price · Currency is EUR 66.05
+0.30 (0.46%)
Jul 24, 2026, 5:35 PM CET
Redcare Pharmacy NV Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -23 | -28.5 | -39 | -17.3 | -69.17 | -65.7 |
Depreciation & Amortization | 76.1 | 75.9 | 68.2 | 57.29 | 39.51 | 26.96 |
Stock-Based Compensation | 3.78 | 3.5 | 3.2 | 9 | 16.23 | 20.54 |
Other Adjustments | - | 0.4 | 0.5 | 0.42 | 1.76 | 1.49 |
Change in Receivables | -38.2 | -18.9 | -8 | -20.32 | -2.28 | -6.58 |
Changes in Inventories | -54.7 | -60.9 | -17.4 | -16.6 | -3.08 | -15.38 |
Changes in Accounts Payable | 65.3 | 68.5 | 25.1 | 56.81 | -12.25 | 26.51 |
Changes in Income Taxes Payable | -2 | -0.6 | -0.6 | -1.44 | -0.46 | -0.18 |
Changes in Other Operating Activities | -7.6 | -3.9 | -3.1 | -1.77 | 0.94 | 24 |
Operating Cash Flow | 16.7 | 31 | 22.1 | 61.46 | -29.11 | 11.64 |
Operating Cash Flow Growth | -56.02% | 40.27% | -64.04% | - | - | -34.64% |
Capital Expenditures | -79.7 | -79.3 | -8.7 | -6.44 | -13.57 | -13.82 |
Purchases of Intangible Assets | -39.2 | -39.3 | -33.4 | -31.78 | -39.96 | -29.34 |
Proceeds from Sale of Investments | - | 0 | 40 | 33.76 | 0.3 | 0.3 |
Cash Acquisitions | - | 0 | 0.3 | -23.44 | -6.02 | -31.18 |
Other Investing Activities | 67.58 | -32.5 | 3.4 | -36.7 | -79.08 | -10.29 |
Investing Cash Flow | -78.2 | -146.6 | 8.4 | -59.96 | -138.01 | -84.3 |
Short-Term Debt Issued | - | - | - | - | - | -0 |
Net Short-Term Debt Issued (Repaid) | - | - | - | - | - | -0 |
Long-Term Debt Issued | - | 296.3 | 0 | 0 | 0 | 235.2 |
Long-Term Debt Repaid | -223.2 | -158.7 | -1.6 | -1.67 | -1.62 | -5.66 |
Net Long-Term Debt Issued (Repaid) | -223.2 | 137.6 | -1.6 | -1.67 | -1.62 | 229.53 |
Issuance of Common Stock | 0.17 | 0.4 | 4 | 32.04 | 0.64 | 12.22 |
Net Common Stock Issued (Repurchased) | 0.17 | 0.4 | 4 | 32.04 | 0.64 | 12.22 |
Other Financing Activities | -22.7 | -26.7 | -20.3 | -15.33 | -12.53 | -12.16 |
Financing Cash Flow | 50.6 | 111.3 | -17.9 | 15.05 | -13.52 | 229.59 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.25 | -0.2 | 0.1 | 0.84 | 0 | 0 |
Net Cash Flow | -11.18 | -4.3 | 12.6 | 16.54 | -180.64 | 156.93 |
Free Cash Flow | -63 | -48.3 | 13.4 | 55.02 | -42.68 | -2.18 |
Free Cash Flow Growth | - | - | -75.64% | - | - | - |
FCF Margin | -2.05% | -1.64% | 0.57% | 3.06% | -3.54% | -0.21% |
Free Cash Flow Per Share | -3.09 | -2.40 | 0.67 | 2.86 | -2.37 | -0.12 |
Levered Free Cash Flow | -263.2 | 99.6 | 16.4 | 74.15 | -68.17 | 203.45 |
Unlevered Free Cash Flow | -22.3 | -23.84 | 25.72 | 73.87 | -52.75 | -14.48 |